Navigation Links
AbbVie Declares Dividend and Announces Share Repurchase Program
Date:2/15/2013

p>Forward-Looking Statements

Some statements in this news release may be forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements.  Economic, competitive, governmental, technological and other factors that may affect AbbVie's operations are discussed in the "Risk Factors" section of the Information Statement attached to our Form 10 Registration Statement, which has been filed with the SEC, and are incorporated by reference.  AbbVie undertakes no obligation to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law.


'/>"/>
SOURCE AbbVie Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioMed Realty Trust Declares Fourth Quarter 2011 Common Stock and Preferred Stock Dividends
2. BioMed Realty Trust Declares Second Quarter 2012 Common Stock And Preferred Stock Dividends
3. Techne Corporation Declares Dividend
4. Techne Corporation Declares Dividend And Announces An Increase In Its Share Repurchase Program
5. Sigma-Aldrich Corporation Declares Increased Quarterly Dividend; Announces Live Webcasts Of Presentations At Two Upcoming Conferences
6. PDL BioPharma Completes Regular Quarterly Dividend Payment
7. Amgen Announces 2012 First Quarter Dividend
8. Osteologix Announces Dividend
9. Amgen Announces 2012 Third Quarter Dividend
10. CryoLife Announces Quarterly Cash Dividend for the Fourth Quarter 2012
11. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... (PRWEB) August 21, 2014 ... biopharmaceutical contract development and manufacturing organization (CMO) announced ... Pharmaceuticals, Inc., an oncology company focused on the ... cancer, to manufacture the anti-prostate specific membrane antigen ... product candidate. Under the agreement the antibody ...
(Date:8/20/2014)... university inventions licensed to biotechnology firms has revealed ... open these roadblocks, the researchers suggest that better ... stage could lead to faster commercialization down the ... discoveries made in university laboratories and licensed to ... trials, which have a high failure rate. But ...
(Date:8/20/2014)... High performance computing (HPC) will ... complete climate and Earth system model to address ... , Eight national laboratories, including Lawrence Livermore ... for Atmospheric Research, four academic institutions and one ... national laboratories include Argonne, Brookhaven, Lawrence Berkeley, Los ...
(Date:8/20/2014)... 20, 2014 Not long ago, it ... should be performed late in the development cycle – ... current regulatory trends suggest that, like many things GxP, ... In recent years, multiple drug sponsors have been required ... specific questions during phase I/II. It’s not only clinical ...
Breaking Biology Technology:Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 3Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2
... ARNA ) announced today that the company is ... Conference on September,11, 2007 at 3:30 p.m. Eastern Time ... New York City. Jack Lief, Arena,s President and Chief,Executive ... the,company and its clinical development and discovery programs. ...
... Pieris AG,a bio-pharmaceutical company developing Anticalins(R), a ... announced successful completion,of a series of preclinical ... disease. The studies reported by Pieris ... VEGF is a key factor in the ...
... the friendly bacteria beloved of yoghurt advertisers, may be ... giving us safer pork products, according to scientists speaking ... General Microbiologys 161st Meeting at the University of Edinburgh, ... from the UKs Veterinary Laboratories Agency in Weybridge, Surrey ...
Cached Biology Technology:Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference 3Probiotic good bugs may control gut infections 2
(Date:8/21/2014)... 18-22, 2014 , WHERE: , San Diego ... CA 92101 , WHAT: , Invited and ... latest research in human genetics. Examples of sessions ... on rare genetic variants in health and disease, ... sun sensitivity (Saturday, Oct. 18, 5:30-7:30 pm) , ...
(Date:8/21/2014)... La. A team of researchers at ... method for using affordable, consumer-grade 3D printers ... that can contain antibacterial and chemotherapeutic compounds ... comprised of doctoral students and research faculty ... engineering programs collaborated to create filament extruders ...
(Date:8/21/2014)... the pancreas digesting itself resulting in severe abdominal pain, ... around 20,000 patients are diagnosed with the disease resulting ... treatment is restricted to intravenous fluid and nutritional support. ... Life Sciences, who led the research, said "The major ... stones and excessive alcohol intake combined with a high ...
Breaking Biology News(10 mins):American Society of Human Genetics 2014 Annual Meeting 2Louisiana Tech University researchers use 3D printers to create custom medical implants 2Louisiana Tech University researchers use 3D printers to create custom medical implants 3Insulin offers new hope for the treatment of acute pancreatitis 2
... Software, the Uniformed Service University of the Health ... the Advancement of Military,Medicine, Inc. (HJF) have entered ... extend their collaborative endeavors in prostate disease,research. The ... differentiate patients with,favorable versus poor prognosis at the ...
... Research, which is strategically funded by BBSRC, is ... bacterial cells to combat potentially dangerous microbial infections. ... bacteria, and IFR has been studying one that ... dangerous source of hospital-acquired infections. New research is ...
... Weizmann Institute scientists have added a significant piece to the ... size as an embryo or organism grows and develops. In ... Naama Barkai and Ben-Zion Shilo and research student Danny Ben-Zvi ... in developing fruit fly wings in which the vein ...
Cached Biology News:Genomatix, USU and HJF execute a CRADA: Prostate cancer prognostic marker discovery by NGS 2Tuning natural antimicrobials to improve their effectiveness at battling superbugs 2Scale models 2
... kit contains 5 ml CELLection Dynabeads (4.5 ... the human epithelial antigen EpCAM and DNase ... log enrichment of epithelial tumour cells directly ... cells clumps can be enriched from bone ...
nucleophosmin (nucleolar phosphoprotein B23, numatrin), mRNA...
Human PDGF R beta MAb (Clone # PR7212)...
... Ambion's ActivePro In Vitro ... an E.coli lysate, synthesizes ... as well as proteins ... than competing kits. This ...
Biology Products: